Publications by authors named "Modi Zhai"

Introduction: Lung neuroendocrine carcinomas (Lu-NECs) are rare, highly aggressive lung tumors with poor prognosis and limited therapeutic options. Understanding the tumor immune microenvironment (TIME) is crucial towards personalized therapeutic strategies.

Objectives: This study aims to systematically characterize the heterogeneity and complexity of the TIME in Lu-NECs by integrating proteomic, transcriptomic, and genomic data.

View Article and Find Full Text PDF

Early detection and intervention of precancerous lesions are crucial in reducing cancer morbidity and mortality. Comprehensive analysis of genomic, transcriptomic, proteomic and epigenomic alterations can provide insights into the early stages of carcinogenesis. However, the lacke of an integrated, well-curated data resource of molecular signatures limits our understanding of precancerous processes.

View Article and Find Full Text PDF

Observational studies and clinical trials have reported potential associations between retinal diseases and psychiatric disorders. However, the causal associations between them have remained elusive. In this study, we used bi-directional two-sample Mendelian randomization (MR) analysis to explore unconfounded causal relationships between retinal diseases and psychiatric disorders using large-scale genome-wide association study (GWAS) summary statistics of over 500,000 participants of European ancestry from the FinnGen project, the Psychiatric Genomics Consortium, the European Bioinformatics Institute, and the UK Biobank.

View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease (AD) is a growing concern due to an aging population, and studying the genetic links between blood metabolites and AD could provide insights into the disease's metabolic issues.
  • The study aimed to explore causal relationships between blood metabolites and AD using Mendelian randomization (MR) analysis, utilizing data from large genome-wide association studies.
  • Researchers identified 40 blood metabolites possibly linked to AD, with two—gamma-glutamylphenylalanine and X-11317—showing significant associations, suggesting blood metabolic changes may influence AD risk rather than vice versa.
View Article and Find Full Text PDF